Please turn JavaScript on

Children's Tumor Foundation

We bring you the latest updates from Children's Tumor Foundation through a simple and fast subscription.

We can deliver your news in your inbox, on your phone or you can read them here on this website on your personal news page.

Unsubscribe at any time without hassle.

Children's Tumor Foundation's title: Home - Children's Tumor Foundation

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.51 / day

Message History

The Children’s Tumor Foundation (CTF) is supporting the addition of a new treatment arm to the INTUITT-NF2 platform clinical trial, an innovative clinical trial designed to accelerate the development of therapies for people living with NF2-related schwannomatosis (NF2-SWN).

This new arm will evaluate a combination of retifanlimab and bevac...


Read full story

At 19, Autumn is making plans for her future. She teaches skiing, loves traveling and collecting perfume, and hopes to pursue a career helping people who are often misunderstood. But alongside those ambitions are fears about her health and what living with neurofibromatosis type 1 (NF1) could mean for the years ahead.

Diagnosed at birth...


Read full story

Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic condition. This means that a person with NF1 has traditionally been understood to have a 50% chance of passing the altered NF1 gene to each child. This follows the principles of


Read full story

A Clinical Research Award will support a multicenter study led by Jonathan J. Rios, PhD, to determine which children are most at risk for scoliosis progression and how future treatments should be evaluated.

The Children’s Tumor Foundation (CTF) has awarded a $200,000 Clinical Research Award to Jonathan J. Rios, PhD, director of Molecular Ge...


Read full story

For families of children living with neurofibromatosis type 1 (NF1), an optic pathway glioma diagnosis can bring difficult questions. Will the tumor affect their child’s vision? Will treatment be necessary? And how can doctors determine the best approach to care?

These questions were the focus of a recent Children’s Tumor Foundation (CTF) webinar: <...


Read full story